- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
CAENORHABDITIS ELEGANS AND APOPTOSIS |
401 |
acts with the transcriptional repressor UNC-37/Groucho to protect CEMs from undergoing apoptosis in males. Interestingly, the second intron of the ceh-30 gene contains two adjacent cis-elements that are binding sites for TRA-1A, the terminal sex determination factor, and UNC-86, a POU-type homeodomain protein that specifies the CEM cell fates. In vitro TRA-1A interacts directly with UNC-86 on intron 2 and may suppress transcriptional activation of ceh-30 by UNC-86, leading to activation of CEM cell death in hermaphrodites that have a high level of TRA-1A. Thus ceh-30 integrates the sex determination signal TRA-1A and the cell fate determination and survival signal UNC-86 to control sex-specific death of CEMs (Figure 34-2). There is evidence that non–egl-1 cell death activator(s) may be directly regulated by CEH-30/UNC-37, although the precise target of CEH-30/UNC-37–mediated transcriptional repression is unclear.
4. EXECUTION
Once the CED-3 caspase is activated, it orchestrates different cell death execution events by cleaving and activating multiple downstream effectors, leading to chromosomal fragmentation, mitochondrial elimination, and removal of apoptotic cells.
4.1. DNA degradation
Fragmentation of chromosomes is a hallmark of apoptosis that aids in dismantling the cell. In dying cells, chromosomes condense and are cleaved between nucleosomes, creating approximately 180 base pair fragments and permanently preventing DNA replication. The contribution of deoxyribonucleases to apoptosis has been enigmatic for many years. It was originally thought that DNA degradation was an expendable event late in apoptosis, because inactivation of the first identified apoptotic nuclease gene, nuc-1 (nuc, abnormal nuclease), did not affect cell death activation or other aspects of apoptosis. Recent studies, however, have shown that DNA degradation actually facilitates apoptosis and clearance of a dying cell.
Currently, at least 10 genes are important for chromosomal degradation, several of which also facilitate clearance of the dying cell by a neighboring cell in C. elegans, which do not have professional phagocytes. These include nuc-1, wah-1 (wah, worm AIF homolog), cps-6 (cps, CED-3 protease suppressor), cyp13 (cyp, cyclophilins), and crn-1 to crn-6 (crn, cell deathrelated nuclease). Loss or reduction of activity in any of these genes results in the accumulation of cells with
3 hydroxyl DNA breaks in C. elegans embryos that can be labeled by the terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) assay. With the exception of nuc-1 and crn-6, a defect in any of these genes also causes delayed or reduced cell death in sensitized genetic backgrounds. These genes seem to act in two distinct pathways to promote apoptotic DNA degradation, with cps-6, wah-1, crn-1, crn-4, crn-5, and cpy13 acting in one pathway and crn-2 and crn-3 acting in another. Interestingly, disrupting both DNA degradation pathways causes a defect in cell corpse engulfment at all stages of embryonic development. One possible explanation for this is that the DNA fragmentation process may facilitate the generation or exposure of “eat me” signals for phagocytosis. For example, nucleosomes can be presented on the surface of T cells and enhance phagocytosis by dendritic cells. However, the exact mechanism by which chromosomal fragmentation promotes clearance of apoptotic cells in C. elegans is unclear.
Both cps-6 and wah-1 encode mitochondrial proteins that are homologs of human endonuclease G (endoG) and apoptosis-inducing factor (AIF), respectively, which are also important for apoptotic DNA degradation in mammals. WAH-1 is released from the mitochondria by the cell death initiator EGL-1 and translocates to the nucleus in a CED-3–dependent manner. WAH-1 also physically binds and enhances the endonuclease activity of CPS-6. Moreover, CPS-6 may form a large DNA degradation complex with CRN-1, CRN-4, CRN-5, and CYP-13 (named the degradeosome) to promote stepwise DNA fragmentation, starting from generation of DNA nicks to single-stranded gaps to double-stranded breaks. On the other hand, nuc-1 and crn-6 encode type II acidic DNases that affect neither cell death nor engulfment. These two nucleases may act at a later stage of the cell death and DNA degradation process.
4.2. Mitochondrial elimination
As described previously, mitochondria play a central role in the killing phase of apoptosis in mammals. Mitochondria undergo dramatic morphological changes during apoptosis, including fragmentation, reorganization of cristae structures, and increased permeability of the outer mitochondrial membrane, all of which have been proposed to promote release of proapoptotic factors such as cytochrome c and Smac/Diablo from mitochondria of mammals. There are also reports that mitochondria are reduced or lost during apoptosis, which would eliminate cellular energy production and contribute to the demise of the cell. A comprehensive genetic and cell biological analysis of components of the C. elegans
402 |
BRIAN L. HARRY AND DING XUE |
mitochondria fission and fusion machinery, such as the dynamin GTPases DRP-1 (drp, dynamin-related protein), FZO-1 (fzo, Fzo mitochondrial fusion protein related), and EAT-3 (eat, eating defective), reveals that defects in mitochondria fission or fusion in C. elegans do not affect apoptosis activation. However, loss of DRP-1 and FIS-2, a homolog of the human Fis1 fission protein, does cause a mild cell death defect that can be detected in sensitized genetic backgrounds, suggesting that fis- 2 and drp-1 have minor proapoptotic roles. Genetic epistatic analysis suggests that fis-2 and drp-1 act independently of one another and downstream of ced-3 to promote apoptosis. Analysis by electron microscopy indicates that mitochondria normally reduced in size or eliminated in apoptotic cells persist in worms deficient in fis-2 or drp-1, suggesting that DRP-1 and FIS- 2 play a role in promoting mitochondrial elimination during apoptosis. Interestingly, active CED-3 protease can cleave DRP-1, and such cleavage is important for DRP-1’s proapoptotic function, but not for its function in mitochondrial fission. Furthermore, the carboxyl terminal cleavage product of DRP-1 appears to be important for activating its proapoptotic function. Therefore, fis-2 and drp-1 represent two novel cell death execution pathways acting downstream of ced-3 to promote mitochondrial elimination (Figure 34-2).
4.3. Engulfment
The timely removal of dying cells is important for development and tissue homeostasis in all organisms, in addition to immune responses and resolution of inflammation in mammals. Apoptotic cells that are not cleared undergo secondary necrosis, which could lead to tissue injury. Genetic analyses have identified many genes that are important for engulfment of apoptotic cells in C. elegans. These genes seem to work in two partially redundant pathways, with ced-1, ced-6, ced-7, and dyn- 1 (dyn, dynamin-related) acting in one pathway and ced-2, ced-5, ced-10, and ced-12 working in another. Most of these genes are required in the engulfing cell, although the activity of ced-7 is also needed in the dying cell. CED-1 is similar to the human scavenging receptor SREC and may function as a receptor on engulfing cells because it clusters around cell corpses in C. elegans. CED-1 clustering requires CED-7, an ATP-binding cassette (ABC) transporter, suggesting that CED-7 may play a role in transporting a signal that CED-1 recognizes or in mediating homophilic interaction between CED-7 on the dying cell and CED-7 on the engulfing cell. The ligands recognized by CED-1 have not been identified,
but CED-6 binds the intracellular portion of CED-1 via a phosphotyrosine binding (PTB) domain. CED-6 may transduce the engulfment signal to reorganize the engulfing cell membrane in response to CED-1 activation, probably through DYN-1, a C. elegans large dynamin GTPase. DYN-1 appears to mediate the internalization and degradation of dying cells by delivering intracellular vesicles to phagocytic cups to support pseudopod extension and to phagosomes to support their maturation and eventual digestion of apoptotic cells. After the internalization of apoptotic cells, multiple Rab GTPases and the HOPS complex mediate the maturation of phagosomes and the degradation of apoptotic cells.
In the other engulfment pathway, ced-2, ced-5, ced10, and ced-12 encode conserved components of the Rac GTPase signaling pathway that are important for rearrangement of the actin cytoskeleton in cell migration and engulfment. CED-2 is a CrkII-like adaptor with one SH2 (Src homology) and two SH3 domains that physically interacts with CED-5, the homolog of human DOCK180. CED-10, the C. elegans homolog of mammalian Rac GTPase, controls cytoskeletal dynamics and cell-shape changes downstream of CED-2 and CED-5. CED-12, a homolog of mammalian ELMO1, contains a potential PH (pleckstrin homology) domain and an SH3binding motif through which it can interact with the CED-2/CED-5 complex. Genetic analyses indicate that ced-2, ced-5, and ced-12 function at the same step but upstream of ced-10 in the engulfment process. Biochemical analyses suggest that CED-2, CED-5, and CED-12 form a ternary complex to activate CED-10 GTPase. The phagocyte receptor for this pathway is poorly characterized. One candidate is PSR-1, the worm phosphatidylserine receptor homolog. PSR-1 binds specifically to cells exposing phosphatidylserine (PS) on their surface and acts in the CED-2/CED-5/CED-12 pathway to promote cell corpse engulfment, probably through interacting with CED-5 and CED-12. However, the engulfment defect of the psr-1(lf) mutant is significantly weaker than that of the ced-2 or ced-5 mutants, suggesting that other phagocyte receptors must also act in this pathway.
Almost all of the genes previously discussed act in phagocytes. Little is known, however, about the “eat-me” signals expressed by apoptotic cells. PS, which normally is restricted to the inner leaflet of the plasma membrane, is externalized during apoptosis and can serve as an “eatme” signal to trigger phagocytosis. Recently, PS exposure on the surface of apoptotic cells in C. elegans has been demonstrated to be important for removal of apoptotic cells. Interestingly, the mitochondrial proapoptotic factor, WAH-1, is involved in promoting PS
